CytomX Therapeutics, Inc. (CTMX)
5.335
-0.10
(-1.75%)
USD |
NASDAQ |
Feb 13, 16:00
5.335
0.00 (0.00%)
After-Hours: 16:58
CytomX Therapeutics Cash from Investing (Quarterly) : 0.439M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| REGENXBIO, Inc. | 42.29M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Alnylam Pharmaceuticals, Inc. | 501.11M |
| Savara, Inc. | 21.47M |
| BioMarin Pharmaceutical, Inc. | -330.96M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.55M |
| Cash from Financing (Quarterly) | 0.253M |
| Free Cash Flow | -72.35M |
| Free Cash Flow Per Share (Quarterly) | -0.0935 |
| Free Cash Flow to Equity (Quarterly) | -14.13M |
| Free Cash Flow to Firm (Quarterly) | -15.42M |
| Free Cash Flow Yield | -11.76% |